AMI Asset Management Corp lowered its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 3.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 372,156 shares of the pharmacy operator’s stock after selling 14,779 shares during the period. Walgreens Boots Alliance accounts for approximately 1.9% of AMI Asset Management Corp’s portfolio, making the stock its 22nd largest position. AMI Asset Management Corp’s holdings in Walgreens Boots Alliance were worth $27,026,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of WBA. Bank of The West lifted its position in shares of Walgreens Boots Alliance by 279.3% in the 2nd quarter. Bank of The West now owns 38,210 shares of the pharmacy operator’s stock worth $2,993,000 after purchasing an additional 28,137 shares during the period. Arvest Bank Trust Division increased its stake in shares of Walgreens Boots Alliance by 1.3% in the 2nd quarter. Arvest Bank Trust Division now owns 92,492 shares of the pharmacy operator’s stock valued at $7,243,000 after acquiring an additional 1,149 shares in the last quarter. Acropolis Investment Management LLC increased its stake in shares of Walgreens Boots Alliance by 4.2% in the 2nd quarter. Acropolis Investment Management LLC now owns 2,625 shares of the pharmacy operator’s stock valued at $206,000 after acquiring an additional 105 shares in the last quarter. NEXT Financial Group Inc increased its stake in shares of Walgreens Boots Alliance by 5.0% in the 2nd quarter. NEXT Financial Group Inc now owns 16,265 shares of the pharmacy operator’s stock valued at $1,274,000 after acquiring an additional 775 shares in the last quarter. Finally, Trust Co. of Vermont increased its stake in shares of Walgreens Boots Alliance by 23.6% in the 2nd quarter. Trust Co. of Vermont now owns 13,102 shares of the pharmacy operator’s stock valued at $1,026,000 after acquiring an additional 2,500 shares in the last quarter. Hedge funds and other institutional investors own 61.24% of the company’s stock.
Walgreens Boots Alliance Inc (NASDAQ WBA) traded up $0.24 during midday trading on Friday, hitting $68.46. 6,664,994 shares of the stock traded hands, compared to its average volume of 5,910,000. Walgreens Boots Alliance Inc has a 12-month low of $63.82 and a 12-month high of $88.00. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96. The company has a market cap of $67,820.00, a price-to-earnings ratio of 18.91, a price-to-earnings-growth ratio of 1.16 and a beta of 1.18.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The firm had revenue of $30.74 billion during the quarter, compared to analyst estimates of $30.39 billion. During the same quarter in the prior year, the business posted $1.10 EPS. The business’s revenue was up 7.9% compared to the same quarter last year. equities analysts forecast that Walgreens Boots Alliance Inc will post 5.71 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Stockholders of record on Thursday, February 15th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $1.60 annualized dividend and a dividend yield of 2.34%. Walgreens Boots Alliance’s payout ratio is 44.20%.
Walgreens Boots Alliance declared that its Board of Directors has authorized a share buyback program on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to purchase shares of its stock through open market purchases. Shares repurchase programs are often a sign that the company’s board believes its shares are undervalued.
WBA has been the subject of several research analyst reports. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, November 10th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research note on Wednesday, December 27th. Vetr upgraded shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, December 12th. Robert W. Baird reiterated an “outperform” rating and issued a $80.00 price objective (down previously from $90.00) on shares of Walgreens Boots Alliance in a research note on Thursday, October 19th. They noted that the move was a valuation call. Finally, Citigroup lowered their price objective on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating for the company in a research note on Thursday, November 2nd. Eleven investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $85.53.
In related news, insider Stefano Pessina purchased 98,858 shares of the business’s stock in a transaction that occurred on Monday, January 15th. The shares were bought at an average cost of $76.07 per share, with a total value of $7,520,128.06. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 14.80% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION NOTICE: This news story was first published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://ledgergazette.com/2018/02/12/ami-asset-management-corp-cuts-position-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.